Errata (DOI:10.1016/S1470-2045(08)70156-6);Effect of preoperative chemoradiation in addition to preoperative chemotherapy: a randomised trial in stage III non-small-cell lung cancer

The Lancet Oncology

Volumn 9, Issue 7, 2008, Pages 636-648

  Thomas, Michael ^a,h   Rübe, Christian ^a,c   Hoffknecht, Petra ^a   Macha, Hans N ^d   Freitag, Lutz ^d   Linder, Albert ^d   Willich, Norman ^a   Hamm, Michael ^e   Sybrecht, Gerhard W ^c   Ukena, Dieter ^c,f   Deppermann, Karl Matthias ^g   Dröge, Cornelia ^a   Riesenbeck, Dorothea ^a   Heinecke, Achim ^a   Sauerland, Cristina ^a   Junker, Klaus ^b   Berdel, Wolfgang E ^a   Semik, Michael ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Center for Pediatrics and Adolescent Medicine   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d Dept of Pulmonary Medicine and Thoracic Surgery   (Germany)

^e Community Hospital Diekholzen ^*  (Germany)

^f Krankenhaus Bremen Ost   (Germany)

^g HELIOS KLINIKUM ERFURT   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; VINDESINE;

ADULT; AGED; ANEMIA; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG FATALITY; DRUG RESPONSE; ESOPHAGITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPENIA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM CANCER; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PATIENT CARE PLANNING; PNEUMONIA; PREOPERATIVE CARE; PRIORITY JOURNAL; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURGICAL MORTALITY; THROMBOCYTOPENIA;

EID: 45849132534     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70221-3     Document Type: Erratum

References (19)

1. Burdett S., Stewart L., and Rydzewska L. A systematic review and meta-analysis of the literature: chemotherapy and surgery versus surgery alone in non-small cell lung cancer. J Thorac Oncol 7 (2006) 611-621
2. van Meerbeeck J., Kramer G., Van Schil P., et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 99 (2007) 442-450
3. Farray D., Mirkovic N., and Albain K. Multimodality therapy for stage III non-small cell lung cancer. J Clin Oncol 23 (2005) 3257-3269
4. Betticher D., Schmitz S., Tötsch M., et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 21 (2003) 1752-1759
5. Albain K., Rusch V., Crowley J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 13 (1995) 1880-1892
6. Choi N., Carey R., Daly W., et al. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer. J Clin Oncol 15 (1997) 712-722
7. Eberhardt W., Wilke H., Stamatis G., et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial. J Clin Oncol 16 (1998) 622-634
8. Thomas M., Rübe M., Semik M., et al. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small-cell lung cancer. J Clin Oncol 17 (1999) 1185-1193
9. 3) non-small cell lung cancer. J Thorac Cardiovasc Surg 122 (2001) 796-802
10. Mountain C. A new international staging system for lung cancer. Chest 89 (1986) 225-233
11. Grunenwald D., and Le Chevalier T. A category of non-small cell lung cancer: A new proposal. J Natl Cancer Inst 98 (1997) 88-89
12. Martini N. Mediastinal lymph node dissection for lung cancer: the memorial experience. Chest Surg Clin N Am 5 (1995) 189-203
13. Junker K., Thomas M., Schulmann K., Klinke F., Bosse U., and Müller K. Tumor regression in non-small-cell lung cancer following neoadjuvant therapy-histological assessment. J Cancer Res Clin Oncol 123 (1997) 469-477
14. Albain K., Swann R., Rusch V., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). J Clin Oncol 23 (2005) 624s (abstr 7014).
15. Vansteenkiste J., Betticher D., Eberhardt W., and De Leyn P. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Thorac Oncol 2 (2007) 684-685
16. Massard G., Ducrocq X., Kochetkova E., Porhanov V., and Riquet M. Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study. Eur J Cardiothorac Surg 30 (2006) 164-167
17. Garrido P., Gonzalez-Larriba J., Insa A., et al. Long term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non-small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901. J Clin Oncol 25 (2007) 4736-4742
18. Rowell N., and O'Rourke N. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 4 (2004) CD002140.pub2.
19. Thomas M., Hoffknecht P., Droege C., et al. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease. Lung Cancer 45 (2004) 99-105